What is the future of treating ALL?
Panel discussion on mantle cell lymphoma
Constantine Tam et al.
What does the TOURMALINE-MM2 study tell us about the use of ixazomib in multiple myeloma?
Pre-leukemic clones that survive chemotherapy are linked to a higher risk of leukemia recurrence
Results of the German acute myeloid leukemia (AML) intergroup study